Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer



Researchers develop ‘Goldilocks drug’ to treat triple-negative breast cancer

Researchers have developed a drug that so specifically targets a deadly kind of breast cancer that there are little to no toxic side effects. Next, it will be tested in phase 1 clinical trials in humans.

Materials provided by University of Arizona. Original written by Mikayla Mace Kelley. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

31st March 2023

Form is (mal)function: Protein's shape lets bacteria disarm it

Read more
30th March 2023

Researchers discover a way to fight the aging process and cancer development

Read more
30th March 2023

Researchers identify cell type that could be key to preventing marrow transplant complication

Read more